Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Eiger BioPharmaceuticals Inc (NASDAQ:EIGR)

7.85
Delayed Data
As of Apr 24
 -0.05 / -0.63%
Today’s Change
7.80
Today|||52-Week Range
23.10
-32.62%
Year-to-Date
No recent news for Eiger BioPharmaceuticals Inc.

Today’s Trading

Previous close7.90
Today’s open8.05
Day’s range7.80 - 8.05
Volume37,699
Average volume (3 months)26,308
Market cap$65.6M
Dividend yield--
Data as of 3:59pm ET, 04/24/2017

Growth & Valuation

Earnings growth (last year)+71.93%
Earnings growth (this year)+33.46%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.61

Competitors

 Today’s
change
Today’s
% change
CAPRCapricor Therapeutic...+0.20+6.47%
XENEXenon Pharmaceutical...+0.11+2.86%
CASICASI Pharmaceuticals...+0.08+6.78%
GTXIGTX Inc+0.01+0.18%
Data as of 2:34pm ET, 04/25/2017

Financials

Next reporting dateMay 15, 2017
EPS forecast (this quarter)-$1.35
Annual revenue (last year)$0.00
Annual profit (last year)-$47.1M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
David A. Cory
Chief Financial &
Principal Accounting Officer
James H. Welch
Corporate headquarters
Palo Alto, California

Forecasts


Search for Jobs